Get Started

DBVT

NASD DBV Technologies SA Sponsored ADR
Oct 25, 2026 · 7:57 PM ET EOD Market Closed

$9.75 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.75, $0.03 below the day’s high of $9.78

YTD change
-49.14%
vs 20-day SMA
-3.07%
vs 200-day SMA
-43.22%

Price ranges

Previous day
$9.45 $9.78
open $9.68 close $9.75
+$0.07 (+0.72%)
Today
$9.45 $9.78
$9.75
Past week
$8.63 $9.92
from $9.11 now $9.75
+$0.64 (+7.03%)
Past month
$8.63 $12.21
from $11.60 now $9.75
-$1.85 (-15.95%)
This year
$8.63 $25.40
from $19.17 now $9.75
-$9.42 (-49.14%)

Price & Performance

-10.64 (-52.18%) / 6M

$7.90$12.59$17.28$21.97Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 98.1% away from all-time highs of $505.70
  • DBVT is down 49% since the beginning of the year
  • DBVT is down 34% over the past 12 months
  • DBVT is down 16% over the past 1 month
  • 2% of all DBVT investors are betting against DBVT

DBVT reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -39.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.12
Earnings momentum +14.3% Quarterly EPS growth
Quarterly change +14.3%

Valuation

P/E ratio N/A
Enterprise value $685.4M
Beta -1.03

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$174.9M
Debt$21.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $577.3M

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,273.46 -2.54%
JNJ Johnson & Johnson $263.81 -1.42%
ABBV AbbVie, Inc. $285.64 +0.16%
MRK Merck & Co., Inc. $145.27 -1.34%
RHHBY Roche Holding Ltd Sponsored ADR $61.17 +2.60%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.